<p>Inhibitory effects of AZD2014 and rapamycin on cell proliferation in A549, PC-9 and SK-MES-1 cells (a, b). (c) Influence of AZD2014 and rapamycin on colony-forming ability of A549 and PC-9 cells, evaluated by clonogenic assay. (d) AZD2014 and rapamycin inhibited mTOR signaling in A549 and SK-MES-1 cells as shown by the decreased phosphorylation of mTORand S6 after treatment for 24h. Cell viability was assessed by MTT, and Colony-forming assay was done as described in Materials and Methods. Columns, mean of three determinations; bars, SD. Results shown are representative of three independent experiments. **, <i>P</i>< 0.01; ***, <i>P</i> < 0.001, control versus AZD2014 or rapamycin-treated cells.</p
A, A52 subcutaneous tumor growth curves when treated with Rapamycin (Rapa; n = 8) and versus placebo...
<p>(A–B) MCF-7 cells were maintained in normal growth media, pretreated with rapamycin (100 nM) for ...
<div><p>Cancer metabolism has greatly interested researchers. Mammalian target of rapamycin (mTOR) i...
<p>(a) Inhibitory effects of rapamycinorAZD2014 combined with 2-DGon cell proliferation in A549 cell...
<p>(a) A549 cells were treated with AZD2014 and rapamycin. (b) PC-9 cells were treated with AZD2014 ...
<p>(A) The concentration-dependent effect of Rapamycin on the anticancer activity of Dasatinib in A5...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
Cancer metabolism has greatly interested researchers. Mammalian target of rapamycin (mTOR) is dysreg...
mTOR (mechanistic target of rapamycin) functions as the central regulator for cell proliferation, gr...
Pemetrexed (PTX), an antifolate drug, has been approved by the US FDA for first line therapy of meso...
The molecular target of rapamycin (mTOR) is up-regulated in glioblastoma (GBM) and this is associate...
<p>(A) Rapamycin enhanced Dasatinib-induced growth inhibition in NCI-H1706 and NCI-H460 cells. NCI-H...
<p>(A) SGC-996 cells were treated with the indicated concentrations of rapamycin for 24, 48 or 72 h....
The mammalian target of rapamycin (mTOR) was originally identified in yeast as the protein responsib...
<p>(A) The indicated cell lines were treated with 2.5 ng/ml TGFβ, 100 nM rapamycin, or TGFβ + rapamy...
A, A52 subcutaneous tumor growth curves when treated with Rapamycin (Rapa; n = 8) and versus placebo...
<p>(A–B) MCF-7 cells were maintained in normal growth media, pretreated with rapamycin (100 nM) for ...
<div><p>Cancer metabolism has greatly interested researchers. Mammalian target of rapamycin (mTOR) i...
<p>(a) Inhibitory effects of rapamycinorAZD2014 combined with 2-DGon cell proliferation in A549 cell...
<p>(a) A549 cells were treated with AZD2014 and rapamycin. (b) PC-9 cells were treated with AZD2014 ...
<p>(A) The concentration-dependent effect of Rapamycin on the anticancer activity of Dasatinib in A5...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
Cancer metabolism has greatly interested researchers. Mammalian target of rapamycin (mTOR) is dysreg...
mTOR (mechanistic target of rapamycin) functions as the central regulator for cell proliferation, gr...
Pemetrexed (PTX), an antifolate drug, has been approved by the US FDA for first line therapy of meso...
The molecular target of rapamycin (mTOR) is up-regulated in glioblastoma (GBM) and this is associate...
<p>(A) Rapamycin enhanced Dasatinib-induced growth inhibition in NCI-H1706 and NCI-H460 cells. NCI-H...
<p>(A) SGC-996 cells were treated with the indicated concentrations of rapamycin for 24, 48 or 72 h....
The mammalian target of rapamycin (mTOR) was originally identified in yeast as the protein responsib...
<p>(A) The indicated cell lines were treated with 2.5 ng/ml TGFβ, 100 nM rapamycin, or TGFβ + rapamy...
A, A52 subcutaneous tumor growth curves when treated with Rapamycin (Rapa; n = 8) and versus placebo...
<p>(A–B) MCF-7 cells were maintained in normal growth media, pretreated with rapamycin (100 nM) for ...
<div><p>Cancer metabolism has greatly interested researchers. Mammalian target of rapamycin (mTOR) i...